Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Vuxen Group AB is a Sweden-based e-commerce company specializing in developing and operating multi-brand online retail platforms primarily in the Nordic region, including Sweden, Norway, Denmark, and Finland. Founded in 2005 and headquartered in Helsingborg, the company serves diverse consumer markets with a focus on sexual health products such as contraceptives, condoms, and adult toys, as well as pet care items for dogs. Beyond retail, Vuxen Group manufactures massage oils, lubricants, and cosmetic as well as intimate products, supplying these to various retailers and distributors across Europe. The company also offers ancillary services including property rental, warehousing, and logistics. Vuxen Group operates several websites catering to its target segments and has transitioned from a niche market to addressing broader consumer needs within sexual health and pet product e-commerce. It is a subsidiary of Money Never Sleeps Holding AB and represents a distinctive player in the Nordic online retail and specialty product markets.
kr 1.51
+kr 0.03 (+2.37%)
EOD Jun 26, 2026 · Twelve Data
Operating margin is thin at 2.28%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 5.1%, steady but not accelerating. Margins contracted 2.3pp, which offsets some of the top-line progress.
ROIC dropped from 6.66% to 3.09%, capital efficiency is deteriorating.
1.2x earnings, 0.7x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 235M
▲ +5.1% YoY
Net Income (TTM)
kr 10M
▼ -55.7% YoY
Op. Margin
5.02%
▼ -2.3pp YoY
ROIC
3.09%
▼ -3.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
kr 17M
▲ +6.9% YoY
Op. Cash Flow (TTM)
kr 23M
▲ +17.2% YoY
Net Debt
-kr 9M
Net Cash Position
Cash & Equiv.
kr 18M
Continue Research
At a P/E of 1.2 and a price-to-free-cash-flow of 0.7, Vuxen Group AB (VUXEN.XSTO) trades below a two-stage DCF intrinsic value of about SEK 81.72 per share, so at SEK 1.51 the stock looks undervalued (5,312.0% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Vuxen Group AB scores 81/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about SEK 81.72 per share for VUXEN.XSTO, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around SEK 61.29. At today's SEK 1.51, that puts the stock about 5,312.0% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Vuxen Group AB scores 81 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. Recent fundamentals include a 5.0% operating margin and a 3.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. VUXEN.XSTO currently trades below its estimated intrinsic value and scores 81/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.